Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) have been given an average rating of “Moderate Buy” by the nine brokerages that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $42.8333.

A number of research analysts have commented on the stock. Zacks Research lowered shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Truist Financial increased their target price on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. Bank of America raised their price target on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Weiss Ratings cut Guardian Pharmacy Services from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 11th. Finally, Oppenheimer upped their price objective on Guardian Pharmacy Services from $38.00 to $43.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th.

Guardian Pharmacy Services Trading Down 3.9%

GRDN stock opened at $39.78 on Wednesday. The company has a market capitalization of $1.98 billion, a P/E ratio of 47.93, a PEG ratio of 2.71 and a beta of 0.05. Guardian Pharmacy Services has a twelve month low of $19.30 and a twelve month high of $44.00. The business has a 50 day simple moving average of $39.40 and a 200-day simple moving average of $35.53.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.24 by $0.05. The firm had revenue of $336.60 million during the quarter, compared to the consensus estimate of $329.89 million. Guardian Pharmacy Services had a net margin of 3.64% and a return on equity of 30.72%. Guardian Pharmacy Services’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.22 EPS. Research analysts predict that Guardian Pharmacy Services will post 1.18 EPS for the current fiscal year.

Institutional Investors Weigh In On Guardian Pharmacy Services

Large investors have recently modified their holdings of the stock. Ameritas Investment Partners Inc. grew its position in Guardian Pharmacy Services by 26.5% in the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after buying an additional 345 shares during the last quarter. Raymond James Financial Inc. purchased a new position in Guardian Pharmacy Services during the 2nd quarter worth $43,000. Strs Ohio acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter worth $75,000. Clearstead Advisors LLC lifted its stake in shares of Guardian Pharmacy Services by 196.3% in the 4th quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock worth $79,000 after acquiring an additional 1,741 shares during the period. Finally, State of Wyoming purchased a new stake in shares of Guardian Pharmacy Services in the second quarter valued at about $58,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.